Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids

  • Authors:
    • Roos Cuperus
    • Godelieve A.M. Tytgat
    • René Leen
    • Pedro Brites
    • Johannes Bras
    • Huib N. Caron
    • André B.P. Van Kuilenburg
  • View Affiliations

  • Published online on: May 1, 2008     https://doi.org/10.3892/ijo.32.5.1011
  • Pages: 1011-1019
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The efficacy and mechanism of action of fenretinide (4-HPR), a vitamin A analogue, was investigated in a panel of six neuroblastoma cell lines and multicellular tumor spheroids. The latter are three dimensional cell aggregates and as such, a model for micrometastases. In all cell lines, the production of reactive oxygen species (ROS) increased with 163-680% after 1 h of treatment with 4-HPR. In addition, a decrease of the mitochondrial membrane potential of 30-75% was observed after 4 h of incubation with 4-HPR. A 6-12-fold difference was observed between the IC50 values for cell proliferation and viability between the most sensitive (IMR32) and most resistant (NASS) cell line towards 4-HPR. Flow cytometric analysis showed an increased amount of apoptotic bodies and no cell-cycle arrest. The antioxidant Trolox completely inhibited the accumulation of 4HPR-induced ROS and prevented the 4HPR-associated cytotoxicity. In all neuroblastoma spheroids, 4-HPR induced a complete cytostasis at clinical relevant concentrations (3-10 µM). Immunohistochemical analysis of 4-HPR-treated spheroids showed a decreased staining for proliferation marker Ki-67 and an increased staining for cleaved-PARP, a marker of apoptosis. Our results suggest that 4-HPR might be a promising agent for the treatment of micrometastases and high-risk neuroblastoma.

Related Articles

Journal Cover

May 2008
Volume 32 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cuperus R, Tytgat GA, Leen R, Brites P, Bras J, Caron HN and Van Kuilenburg AB: Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids. Int J Oncol 32: 1011-1019, 2008
APA
Cuperus, R., Tytgat, G.A., Leen, R., Brites, P., Bras, J., Caron, H.N., & Van Kuilenburg, A.B. (2008). Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids. International Journal of Oncology, 32, 1011-1019. https://doi.org/10.3892/ijo.32.5.1011
MLA
Cuperus, R., Tytgat, G. A., Leen, R., Brites, P., Bras, J., Caron, H. N., Van Kuilenburg, A. B."Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids". International Journal of Oncology 32.5 (2008): 1011-1019.
Chicago
Cuperus, R., Tytgat, G. A., Leen, R., Brites, P., Bras, J., Caron, H. N., Van Kuilenburg, A. B."Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids". International Journal of Oncology 32, no. 5 (2008): 1011-1019. https://doi.org/10.3892/ijo.32.5.1011